BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 30987161)

  • 1. FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus.
    Donate-Correa J; Martín-Núñez E; Ferri C; Hernández-Carballo C; Tagua VG; Delgado-Molinos A; López-Castillo Á; Rodríguez-Ramos S; Cerro-López P; López-Tarruella VC; Arévalo-González MA; Pérez-Delgado N; Mora-Fernández C; Navarro-González JF
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 30987161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Altered Mineral Metabolism on Pathological Cardiac Remodeling in Elevated Fibroblast Growth Factor 23.
    Leifheit-Nestler M; Richter B; Basaran M; Nespor J; Vogt I; Alesutan I; Voelkl J; Lang F; Heineke J; Krick S; Haffner D
    Front Endocrinol (Lausanne); 2018; 9():333. PubMed ID: 29977226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of FGF23/KLOTHO system in human vascular tissue.
    Donate-Correa J; Mora-Fernández C; Martínez-Sanz R; Muros-de-Fuentes M; Pérez H; Meneses-Pérez B; Cazaña-Pérez V; Navarro-González JF
    Int J Cardiol; 2013 Apr; 165(1):179-83. PubMed ID: 21945708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of Klotho and FGF23 in cardiovascular outcomes of diabetic patients with chronic limb threatening ischemia: a prospective study.
    Biscetti F; Rando MM; Cecchini AL; Nicolazzi MA; Rossini E; Angelini F; Iezzi R; Eraso LH; Dimuzio PJ; Pitocco D; Gasbarrini A; Massetti M; Flex A
    Sci Rep; 2023 Apr; 13(1):6150. PubMed ID: 37061530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients.
    Malyszko J; Koc-Zorawska E; Matuszkiewicz-Rowinska J; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2647-50. PubMed ID: 25380886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
    Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
    Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibroblast growth factor 23 and Klotho as cardiovascular risk factors in heart transplant recipients.
    Przybylowski P; Wasilewski G; Janik L; Kozlowska S; Nowak E; Malyszko J
    Transplant Proc; 2014 Oct; 46(8):2848-51. PubMed ID: 25380933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Klotho expression in long bones regulates FGF23 production during renal failure.
    Kaludjerovic J; Komaba H; Sato T; Erben RG; Baron R; Olauson H; Larsson TE; Lanske B
    FASEB J; 2017 May; 31(5):2050-2064. PubMed ID: 28183805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FGF23-klotho axis, bone fractures, and arterial stiffness in dialysis: a case-control study.
    Desbiens LC; Sidibé A; Ung RV; Fortier C; Munger M; Wang YP; Bisson SK; Marquis K; Agharazii M; Mac-Way F
    Osteoporos Int; 2018 Oct; 29(10):2345-2353. PubMed ID: 29959497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble Klotho causes hypomineralization in Klotho-deficient mice.
    Minamizaki T; Konishi Y; Sakurai K; Yoshioka H; Aubin JE; Kozai K; Yoshiko Y
    J Endocrinol; 2018 Jun; 237(3):285-300. PubMed ID: 29632215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Klotho ablation converts the biochemical and skeletal alterations in FGF23 (R176Q) transgenic mice to a Klotho-deficient phenotype.
    Bai X; Dinghong Q; Miao D; Goltzman D; Karaplis AC
    Am J Physiol Endocrinol Metab; 2009 Jan; 296(1):E79-88. PubMed ID: 18984852
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of klotho gene polymorphism and the regulation of calcium-phosphate metabolism disorders in patients with end-stage renal disease.
    Zeng QY; Xia ZY; Tong YS; Sun L; Mou HB; Chen R; Bi GY; Liu CH
    Nephrology (Carlton); 2019 Oct; 24(10):1001-1008. PubMed ID: 30537427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factor 23 inhibits osteoblastic gene expression and induces osteoprotegerin in vascular smooth muscle cells.
    Nakahara T; Kawai-Kowase K; Matsui H; Sunaga H; Utsugi T; Iso T; Arai M; Tomono S; Kurabayashi M
    Atherosclerosis; 2016 Oct; 253():102-110. PubMed ID: 27599364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the Klotho/FGF23/Egr1 signaling pathway on calcium-phosphorus metabolism in diabetic nephropathy and the intervention of Shenyuan granules.
    Zou XR; Zhan LR; Chen L; Long QH; Yuan J; Wang L; Wang XQ
    J Biol Regul Homeost Agents; 2019; 33(6):1695-1702. PubMed ID: 31989808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease.
    Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R
    Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients].
    Gan L; Zhou Q
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmatic Klotho and FGF23 Levels as Biomarkers of CKD-Associated Cardiac Disease in Type 2 Diabetic Patients.
    Silva AP; Mendes F; Carias E; Gonçalves RB; Fragoso A; Dias C; Tavares N; Café HM; Santos N; Rato F; Leão Neves P; Almeida E
    Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30934737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cardiac FGF23/FGFR4 expression is associated with left ventricular hypertrophy in patients with chronic kidney disease.
    Leifheit-Nestler M; Große Siemer R; Flasbart K; Richter B; Kirchhoff F; Ziegler WH; Klintschar M; Becker JU; Erbersdobler A; Aufricht C; Seeman T; Fischer DC; Faul C; Haffner D
    Nephrol Dial Transplant; 2016 Jul; 31(7):1088-99. PubMed ID: 26681731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble Klotho levels in diabetic nephropathy: relationship with arterial stiffness.
    Inci A; Sari F; Olmaz R; Coban M; Dolu S; Sarikaya M; Ellidag HY
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(15):3230-7. PubMed ID: 27466997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Klotho and fibroblast growth factor 23 levels in diabetic nephropathy with different stages of albuminuria.
    Inci A; Sari F; Coban M; Olmaz R; Dolu S; Sarıkaya M; Yılmaz N
    J Investig Med; 2016 Aug; 64(6):1128-33. PubMed ID: 27323770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.